MCF10A

Export

non-transformed mammary epithelial cell line

Cell Type:
Mammary Epith.
Tissue Origin:
breast
Species:
human
Research Area:
Cancer Research/Cell Biology
Cell Characteristics:
Adherent

Recommended Media

DMEM:F12

DMEM:F12 combines the richness of F12 with the higher component concentrations of DMEM. This medium is well suited for clonal density cultures and has been extensively used to demonstrate the effect of various hormones and growth factors on target tissues.

Storage = 2ºC to 8ºC

12-719 = 3.151 g/L glucose, L-glutamine and 15mM HEPES
BE04-687Q = 3.151 g/L glucose and L-glutamine, without HEPES
BE04-687F/U1 = 3.151 g/L glucose and Ultraglutamine I, without HEPES

Mammary Epithelial Cell Growth Medium

Serum-free media developed specifically for growth of mammary epithelial cells.

Available in phenol red-free (basal media = CC3153) and sodium bicarbonate-free (basal media = CC-3152) versions.

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
V T-024 1e6 58% 95% Plasmid (general) 2 µg 100 µl I/II/2b
T T-020 65% 90% Plasmid (general) 2 µg 100 µl I/II/2b
T T-024 65% 90% Plasmid (general) 2 µg 100 µl I/II/2b
SE 96-FF-130 3e4 50-60% good Plasmid (general) 20 µl Shuttle
SE 96-FF-130 2e5 50-60% good Plasmid (general) 400 ng 20 µl Shuttle
SE 96-FF-130 2e5 90% good Plasmid (general) 400 ng 20 µl Shuttle
L X-001 1e6 69% 92% Plasmid (general) 2 µg 100 µl I/II/2b
L X-005 1e6 85% 77% Plasmid (general) 2 µg 100 µl I/II/2b
L T-020 1e6 92% 65% Plasmid (general) 2 µg 100 µl I/II/2b
SE DS-138 2e5 90% 90% Plasmid (general) 20 µl 4D X-Unit

Citations

Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study
Categories:
Classical Media and Reagents, Serum-free and Speciality Media 
Authors:
Ahmadipour F, Noordin MI, Mohan S, Arya A, Paydar M, Looi CY, Keong YS, Siyamak EN, Fani S, Firoozi M, Yong CL1, Sukari MA, Kamalidehghan B 
In:
Other (2015) 9: 1193-208 
Targeting MKK3 as a novel anticancer strategy: molecular mechanisms and therapeutical implications
Categories:
Classical Media and Reagents, Serum-free and Speciality Media 
Authors:
Baldari S, Ubertini V, Garufi A, D\\\'Orazi G, Bossi G 
In:
Cell Death Dis. (2015) 6: e1621 
Novel inhibitors induce large conformational changes of GAB1 pleckstrin homology domain and kill breast cancer cells
Categories:
Classical Media and Reagents, Serum-free and Speciality Media 
Authors:
Chen L, Du-Cuny L, Moses S, Dumas S, Song Z, Rezaeian AH, Lin HK, Meuillet EJ, Zhang S 
In:
Other (2015) 11(1): e1004021 
Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells
Categories:
Classical Media and Reagents, Serum-free and Speciality Media 
Authors:
Youhong Liu, Lin Chen, Zhicheng Gong, Liangfang Shen, Chinghai Kao, Janet M. Hock, Lunquan Sun and Xiong Li 
In:
OncoTarget (2014) 6(5): 3055-70 
BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer
Categories:
Transfection 
Authors:
Xia W, Nagase S, Montia AG, Kalachikov SM, Keniry M, Su T, Memeo L, Hibshoosh H, Parsons R 
In:
Cancer Res (2008) 68(6): 1667-74 
Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer
Categories:
Transfection 
Authors:
Shulewitz M, Soloviev I, Wu T, Koeppen H, Polakis P, Sakanaka C 
In:
Oncogene (2006) 25(31): 4361-9 

Privacy | Legal | About Lonza

©2019 Lonza. All rights reserved.